EUVIMEDOpdag EUVIMED
Open access · CC BY-NC 4.0

Spontaneous Bacterial Peritonitis Is Associated With High Mortality, Which Interacts With Antibiotic Prophylaxis in a National Cirrhosis Cohort

Scott Silvey, Nilang Patel, Jacqueline G O'Leary, Timothy Morgan, John D Markley, Sofia S Jakab, Heather Patton, Shari Rogal, Jasmohan S Bajaj

Alimentary Pharmacology & Therapeutics · 2026-04 · 63 (8) · 1109-1118

DOI: 10.1111/apt.70498 ↗

At a glance

Journal article in Alimentary Pharmacology & Therapeutics, published online on 2025-12-21. Written by Scott Silvey and 8 co-authors. Institution: Department of Population Health, Virginia Commonwealth University, Richmond, Virginia, USA. Major MEDLINE topics: Peritonitis, Liver Cirrhosis, Antibiotic Prophylaxis, Bacterial Infections. Cited 3 times so far (Crossref); 38 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: U.S. Department of Veterans Affairs, NCATS NIH HHS, National Center for Advancing Translational Sciences.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

With changes in bacteriology and cirrhosis demographics, the impact of spontaneous bacterial peritonitis (SBP) on cirrhosis outcomes needs re‐evaluation.

Aim

Determine the importance of SBP on mortality and liver transplant (LT) across occurrence/recurrence and prophylaxis in a national cohort of Veterans with decompensated cirrhosis.

Method

Veterans admitted with their first hepatic decompensation between 2009 and 2019 were evaluated for SBP development, and use of primary/secondary SBP prophylaxis (PSPr/SSPr) to determine the associations between SBP and interaction with mortality and LT.

Results

52,392 Veterans were included and followed for 7.51 ± 3.83 years, during which 77% died and 2.4% received LT. 16.7% developed one SBP episode, 2.3% two episodes and 0.8% ≥ 3 episodes. Patients on PSPr versus not showed a 24% higher mortality risk, those on SSPr versus not had a 5% increased mortality risk with first and 28% higher mortality risk with additional recurrences. SBPPr interacted with SBP episode number (1.4× PSPr and 1.76× for SSPr) for mortality but not LT. SBP cultures showed higher resistance with increasing SBP episodes (2nd vs. 1st: OR = 2.51, p < 0.001; ≥ 3 vs. 2nd: OR = 7.84, p < 0.001) and with SBPPr (PSPr vs. no prophylaxis: OR = 2.30; SSPr vs. no at first recurrence: OR = 3.70; SSPr vs. no at ≥ 2 recurrences: OR = 10.79, all p < 0.001). Despite documented resistance on PSPr, 82% of patients were continued on the same medication for SSPr, with similar rates of continuation after repeat infection while on SSPr.

Conclusion

In a national cohort of newly decompensated cirrhosis Veterans, SBP increased mortality, which worsened with recurrence. SBP prophylaxis (primary or secondary) showed an interaction with higher mortality but not LT. Antibiotic resistance increased with SBPPr, but culture results were not followed while resuming/initiating SBPPr. Novel strategies to prevent SBP recurrence and mortality are needed.

Subjects

MeSH terms (MEDLINE)

PeritonitisLiver CirrhosisAntibiotic ProphylaxisBacterial InfectionsAnti-Bacterial AgentsHumansMaleFemaleMiddle AgedAgedLiver TransplantationCohort StudiesUnited StatesVeteransRecurrence

Substances

Anti-Bacterial Agents

Authors and institutions

  • Department of Population Health, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Division of Nephrology, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, Virginia, USA.
  • GI Section, Dallas VA Medical Center, Dallas, Texas, USA.
  • GI Section, Long Beach VA Medical Center, Long Beach, California, USA.
  • Division of Infectious Diseases, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, Virginia, USA.
  • GI Section, West Haven VA Medical Center, West Haven, Connecticut, USA.

Funding

  • U.S. Department of Veterans Affairs
  • NCATS NIH HHS
  • National Center for Advancing Translational Sciences

Cite

APA

Silvey, S., Patel, N., O'Leary, J. G., Morgan, T., Markley, J. D., Jakab, S. S., Patton, H., Rogal, S., & Bajaj, J. S. (2026). Spontaneous Bacterial Peritonitis Is Associated With High Mortality, Which Interacts With Antibiotic Prophylaxis in a National Cirrhosis Cohort. Alimentary Pharmacology & Therapeutics, 63(8), 1109-1118. https://doi.org/10.1111/apt.70498

Vancouver

Silvey S, Patel N, O'Leary JG, Morgan T, Markley JD, Jakab SS, et al. Spontaneous Bacterial Peritonitis Is Associated With High Mortality, Which Interacts With Antibiotic Prophylaxis in a National Cirrhosis Cohort. Alimentary Pharmacology & Therapeutics. 2026;63(8):1109-1118. doi:10.1111/apt.70498

BibTeX
@article{Silvey2026,
  author = {Silvey, Scott and Patel, Nilang and O'Leary, Jacqueline G and Morgan, Timothy and Markley, John D and Jakab, Sofia S and Patton, Heather and Rogal, Shari and Bajaj, Jasmohan S},
  title = {Spontaneous Bacterial Peritonitis Is Associated With High Mortality, Which Interacts With Antibiotic Prophylaxis in a National Cirrhosis Cohort},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {63},
  number = {8},
  pages = {1109--1118},
  doi = {10.1111/apt.70498}
}
Start for free →